Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12798429rdf:typepubmed:Citationlld:pubmed
pubmed-article:12798429lifeskim:mentionsumls-concept:C0025517lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C0014272lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C0969677lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C1383860lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C0043791lld:lifeskim
pubmed-article:12798429lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:12798429pubmed:issue3lld:pubmed
pubmed-article:12798429pubmed:dateCreated2003-6-11lld:pubmed
pubmed-article:12798429pubmed:abstractTextThe juvenile visceral steatosis (JVS) mouse, a murine model of systemic carnitine deficiency, shows a disorder of fatty acid oxidation and develops cardiac hypertrophy associated with lipid accumulation. Recently, alpha-tocopherol was shown to decrease 1,2-diacylglycerol (DAG) levels. We investigated the involvement of DAG in cardiac hypertrophy due to energy metabolism disorder by evaluating the effects of alpha-tocopherol administration on the hearts of JVS mice.lld:pubmed
pubmed-article:12798429pubmed:languageenglld:pubmed
pubmed-article:12798429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:citationSubsetIMlld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12798429pubmed:statusMEDLINElld:pubmed
pubmed-article:12798429pubmed:monthJunlld:pubmed
pubmed-article:12798429pubmed:issn0008-6363lld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:ItoMasafumiMlld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:MatsuiHideoHlld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:OkumuraKenjiKlld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:MuroharaToyoa...lld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:KamiyaHirokiHlld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:SaburiYoshihi...lld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:AsaiToruTlld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:TakahashiRyot...lld:pubmed
pubmed-article:12798429pubmed:authorpubmed-author:MatsubaraKeni...lld:pubmed
pubmed-article:12798429pubmed:issnTypePrintlld:pubmed
pubmed-article:12798429pubmed:day1lld:pubmed
pubmed-article:12798429pubmed:volume58lld:pubmed
pubmed-article:12798429pubmed:ownerNLMlld:pubmed
pubmed-article:12798429pubmed:authorsCompleteYlld:pubmed
pubmed-article:12798429pubmed:pagination565-74lld:pubmed
pubmed-article:12798429pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:meshHeadingpubmed-meshheading:12798429...lld:pubmed
pubmed-article:12798429pubmed:year2003lld:pubmed
pubmed-article:12798429pubmed:articleTitleImpact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol.lld:pubmed
pubmed-article:12798429pubmed:affiliationDepartment of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.lld:pubmed
pubmed-article:12798429pubmed:publicationTypeJournal Articlelld:pubmed